Binosto 70 mg Noruega - norueguês - Statens legemiddelverk

binosto 70 mg

pharmaprim ab - alendronatnatriumtrihydrat - brusetablett - 70 mg

Adartrel 0.25 mg Noruega - norueguês - Statens legemiddelverk

adartrel 0.25 mg

glaxosmithkline as - ropinirolhydroklorid - tablett, filmdrasjert - 0.25 mg

Adartrel 2 mg Noruega - norueguês - Statens legemiddelverk

adartrel 2 mg

glaxosmithkline as - ropinirolhydroklorid - tablett, filmdrasjert - 2 mg

Symkevi União Europeia - norueguês - EMA (European Medicines Agency)

symkevi

vertex pharmaceuticals (ireland) limited - tezacaftor, ivacaftor - cystisk fibrose - andre åndedrettsprodukter - symkevi is indicated in a combination regimen with ivacaftor tablets for the treatment of patients with cystic fibrosis (cf) aged 6 years and older who are homozygous for the f508del mutation or who are heterozygous for the f508del mutation and have one of the following mutations in the cystic fibrosis transmembrane conductance regulator (cftr) gene: p67l, r117c, l206w, r352q, a455e, d579g, 711+3a→g, s945l, s977f, r1070w, d1152h, 2789+5g→a, 3272 26a→g, and 3849+10kbc→t.

Coxevac União Europeia - norueguês - EMA (European Medicines Agency)

coxevac

ceva santé animale - inaktivert coxiella burnetii-vaksine, stamme nine mile - immunologicals for bovidae, inactivated bacterial vaccines (including mycoplasma, toxoid and chlamydia) - goats; cattle - cattle: , for the active immunisation of cattle to lower the risk for non-infected animals vaccinated when non-pregnant to become shedder (5 times lower probability in comparison with animals receiving a placebo), and to reduce shedding of coxiella burnetii in these animals via milk and vaginal mucus. , onset of immunity: not established. , duration of immunity: 280 days after completion of the primary vaccination course. , goats: , for the active immunisation of goats to reduce abortion caused by coxiella burnetii and to reduce shedding of the organism via milk, vaginal mucus, faeces and placenta. , onset of immunity: not established. , duration of immunity: one year after completion of the primary vaccination course.

Cinacalcet Aristo 30 mg Noruega - norueguês - Statens legemiddelverk

cinacalcet aristo 30 mg

aristo pharma gmbh - cinacalcethydroklorid - tablett, filmdrasjert - 30 mg

Cinacalcet Aristo 60 mg Noruega - norueguês - Statens legemiddelverk

cinacalcet aristo 60 mg

aristo pharma gmbh - cinacalcethydroklorid - tablett, filmdrasjert - 60 mg

Cinacalcet Aristo 90 mg Noruega - norueguês - Statens legemiddelverk

cinacalcet aristo 90 mg

aristo pharma gmbh - cinacalcethydroklorid - tablett, filmdrasjert - 90 mg

Cozaar 12.5 mg Noruega - norueguês - Statens legemiddelverk

cozaar 12.5 mg

merck sharp & dohme b.v. - losartankalium - tablett, filmdrasjert - 12.5 mg